Pediaderm Ta | Triamcinolone Acetonide Cream Breastfeeding
There are high number of clear evidence that breastfeeding provides best nutrition that you can give to your baby. It is also evident that lactation is good for mothers health as well. Evolution has designed breastfeeding in a way that it caters all nutritional need of your child. However modern medicine is quite new for evolution, that is why mothers body is not well prepared to filter unnecessary chemical found in medicines. It becomes a necessity to figure out which drug is safe and which drug is dangerous for your newborn while nursing. In this article we will understand function of Pediaderm Ta | Triamcinolone Acetonide Cream and its suitability with breastfeeding.

What is Pediaderm Ta | Triamcinolone Acetonide Cream used for?


Triamcinolone acetonide cream is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

I am currently breastfeeding and I want to know if using Pediaderm Ta | Triamcinolone Acetonide Cream is safe for my kid? Does it have any effect on milk production?

Pediaderm Ta | Triamcinolone Acetonide Cream low risk for breastfeeding
Triamcinolone acetonide is the one and only active ingredient present in Pediaderm Ta | Triamcinolone Acetonide Cream. Triamcinolone acetonide in itself is a low risk drug for lactation so it is easy to understand that Pediaderm Ta | Triamcinolone Acetonide Cream also comes in category of Low Risk item while breastfeeding. Below is the summary of Triamcinolone acetonide in breastfeeding.

Statement of Manufacturer/Labeler about breastfeeding usage
Nursing Mothers It is not known whether topical administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in breast milk. Systemically administered corticosteroids are secreted into breast milk in quantities not likely to have a deleterious effect on the infant. Nevertheless, caution should be exercised when topical corticosteroids are administered to a nursing woman.

Pediaderm Ta | Triamcinolone Acetonide Cream Breastfeeding Analsys


Triamcinolone acetonide while Breastfeeding

Low Risk

CAS Number: 76-25-5

A corticosteroid with a mainly glucocorticoid action and anti-inflammatory effects of similar strength to that of prednisolone.Systemic administration (oral, injection), inhaled (bronchial, nasal), intra-articular, intravitreous and topical.Indicated in the treatment of rheumatic diseases and collagen, inflammatory bowel disease, dermatitis, asthma, rhinitis, etc. This comment is about systemic, intra-articular and ophthalmic triamcinolone. Since the last update we have not found published data about its excretion in breast milk. Administration of intra-articular triamcinolone in the wrist (Smuin 2016) or via an epidural in the cervical area (McGuire 2012) caused a temporary decrease in the production of milk lasting between one and four weeks that was resolved in both cases via the continuation and stimulation of breastfeeding. The same has occurred, with a shorter duration, following the intra-articular administration of methylprednisolone (Babwah 2013). Although after the administration of triamcinolone, both intraocular (Shen 2010, Degenring 2004), and epidural (Hooten 2016), elimination half-life is about 22-25 days, plasma levels are indetectable or very low, not clinically significant. The maximum concentration peak after these types of administration occurs at 24 hours (Hooten 2016, Shen 2010, Degenring 2004). There is consensus among experts that, in general, neither systemic corticoids nor inhaled ones present a breastfeeding contraindication (National Asthma Education 2004). The low plasma levels obtained after ophthalmic administration suggest a very low risk during breastfeeding. Corticoids are of commonally used in pediatrics and have no side effects when they are used in isolation or in short-term treatments. Until there is more published data about this drug in relation to breastfeeding, alternatives with a safer known pharmacokinetic profile for breastfeeding may be preferable (greater protein binding, lesser half-life and less oral bioavailability), especially during the neonatal period and in case of prematurity. If used during breastfeeding it is advisable to monitor milk production. See below the information of these related products:



What should I do if I am breastfeeding mother and I am already exposed to Pediaderm Ta | Triamcinolone Acetonide Cream?

During whole lactation period you shall first discuss with your doctor and then together you shall decide whether you shall take that drug or not however if you have already taken Pediaderm Ta | Triamcinolone Acetonide Cream then you shall inform your doctor, But you should not be worried too much as Pediaderm Ta | Triamcinolone Acetonide Cream comes in category of low risk drug.


My health care provider has asked me to use Pediaderm Ta | Triamcinolone Acetonide Cream, what to do?

Pediaderm Ta | Triamcinolone Acetonide Cream comes in category of low risk and if your doctor is aware that you are breastfeeding it should be ok to use without much concerns.


If I am using Pediaderm Ta | Triamcinolone Acetonide Cream, will my baby need extra monitoring?

Not much


Who can I talk to if I have questions about usage of Pediaderm Ta | Triamcinolone Acetonide Cream in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients